Pharmacogenetics of carbamazepine
Carbamazepine (CMZ) is a drug from the group of anticonvulsants, similar in chemical structure to tricyclic antidepressants. CMZ is widely used for mental disorders and neurological diseases. The lecture discusses the safety of CMZ in respect to personalized medicine, while considering the pharmacog...
Saved in:
| Main Authors: | N. A. Shnayder, E. N. Bochanova, D. V. Dmitrenko, R. F. Nasyrova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2020-01-01
|
| Series: | Эпилепсия и пароксизмальные состояния |
| Subjects: | |
| Online Access: | https://www.epilepsia.su/jour/article/view/503 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mechanisms of development of antipsychotic-induced metabolic disorders: pharmacogenetic aspect
by: R. F. Nasyrova, et al.
Published: (2018-01-01) -
Ethical Considerations in Carbamazepine Pharmacogenomics Testing
by: Madeline Yuzwa, et al.
Published: (2025-08-01) -
Genetic Risk Factors for Adverse Drug Reactions
by: D. A. Sychev, et al.
Published: (2022-04-01) -
Pharmacokinetics and Pharmacogenetics of Apixaban
by: A. V. Savinova, et al.
Published: (2020-11-01) -
The pharmacogenetics antiepileptic drugs
by: N. A. Shnayder, et al.
Published: (2008-12-01)